ロード中...
A solid lipid nanoparticle formulation of 4-(N)-docosahexaenoyl 2′, 2′-difluorodeoxycytidine with increased solubility, stability, and antitumor activity
Previously, we synthesized 4-(N)-docosahexaenoyl 2′, 2′-difluorodeoxycytidine (DHA-dFdC), a novel lipophilic compound with a potent, broad-spectrum antitumor activity. Herein, we report a solid lipid nanoparticle (SLN) formulation of DHA-dFdC with improved apparent aqueous solubility, chemical stabi...
保存先:
| 出版年: | Int J Pharm |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6824728/ https://ncbi.nlm.nih.gov/pubmed/31415878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2019.118609 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|